Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fenlean (FLZ) is currently conducting a phase I trial in the Institute of pharmacy, Chinese Academy of medical sciences as a potential treatment for Parkinson's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 1,520.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,500.00 |
Description | Fenlean (FLZ) is currently conducting a phase I trial in the Institute of pharmacy, Chinese Academy of medical sciences as a potential treatment for Parkinson's disease. |
Synonyms | FLZ |
Molecular Weight | 449.5 |
Formula | C26H27NO6 |
CAS No. | 863193-70-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fenlean 863193-70-8 FLZ inhibitor inhibit